A Leishmania infantum cytosolic tryparedoxin activates B cells to secrete interleukin-10 and specific immunoglobulin

Immunology

Volumn 123, Issue 4, 2008, Pages 555-565

  Menezes Cabral, Sofia ^a   Leal Silvestre, Ricardo ^a   Moreira Santarém, Nuno ^a   Costa Tavares, Joana ^a   Franco Silva, Ana ^a   Cordeiro da Silva, Anabela ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

B cells; Interleukin 10; Leishmania infantum; LiTXN1; Specific antibodies

Indexed keywords

CELL MARKER; CYTOKINE; CYTOPLASM PROTEIN; HYDROPEROXIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; INTERLEUKIN 10; PROTEIN TRYPAREDOXIN; PROTOZOAL PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL FUNCTION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; HUMORAL IMMUNITY; IMMUNOREACTIVITY; IN VITRO STUDY; LEISHMANIA INFANTUM; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CYTOSOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; INTERLEUKIN-10; LEISHMANIA INFANTUM; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; THIOREDOXINS; UP-REGULATION;

EID: 39549123620     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02725.x     Document Type: Article

References (60)

1. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 2001 95 : 239 43.
2. Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A, Teixeira R, Johnson WD Jr. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986 154 : 1003 11.
3. Kaye PM. Costimulation and the regulation of antimicrobial immunity. Immunol Today 1995 16 : 423 7.
4. Heinzel FP, Sadick MD, Mutha SS, Locksley RM. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991 88 : 7011 5.
5. Matthews DJ, Emson CL, McKenzie GJ, Jolin HE, Blackwell JM, McKenzie AN. IL-13 is a susceptibility factor for Leishmania major infection. J Immunol 2000 164 : 1458 62.
6. Barral-Netto M, Barral A, Brodskyn C, Carvalho EM, Reed SG. Cytotoxicity in human mucosal and cutaneous leishmaniasis. Parasite Immunol 1995 17 : 21 8.
7. Galvao-Castro B, Sa Ferreira JA, Marzochi KF, Marzochi MC, Coutinho SG, Lambert PH. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis. Clin Exp Immunol 1984 56 : 58 66.
8. Launois P, Ohteki T, Swihart K, MacDonald HR, Louis JA. In susceptible mice, Leishmania major induces very rapid interleukin-4 production by CD4+ T cells which are NK1.1. Eur J Immunol 1995 25 : 3298 307.
9. Cordeiro-Da-Silva A, Borges MC, Guilvard E, Ouaissi A. Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation. Infect Immun 2001 69 : 6588 96.
10. Frankenburg S, Leibovici V, Mansbach N, Turco SJ, Rosen G. Effect of glycolipids of Leishmania parasites on human monocyte activity. Inhibition by lipophosphoglycan. J Immunol 1990 145 : 4284 9.
11. Suffia I, Ferrua B, Stien X, Mograbi B, Marty P, Rousseau D, Fragaki K, Kubar J. A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis. Infect Immun 2000 68 : 630 6.
12. Stevens JR, Noyes HA, Schofield CJ, Gibson W. The molecular evolution of Trypanosomatidae. Adv Parasitol 2001 48 : 1 56.
13. Wilson ME, Young BM, Davidson BL, Mente KA, McGowan SE. The importance of TGF-beta in murine visceral leishmaniasis. J Immunol 1998 161 : 6148 55.
14. Satoskar A, Bluethmann H, Alexander J. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect Immun 1995 63 : 4894 9.
15. Goto H, Lindoso JA. Immunity and immunosuppression in experimental visceral leishmaniasis. Braz J Med Biol Res 2004 37 : 615 23.
16. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991 146 : 3444 51.
17. Bacellar O, Brodskyn C, Guerreiro J, Barral-Netto M, Costa CH, Coffman RL, Johnson WD, Carvalho EM. Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis. J Infect Dis 1996 173 : 1515 8.
18. Castro H, Sousa C, Novais M, Santos M, Budde H, Cordeiro-da-Silva A, Flohe L, Tomas AM. Two linked genes of Leishmania infantum encode tryparedoxins localised to cytosol and mitochondria. Mol Biochem Parasitol 2004 136 : 137 47.
19. Santarem N, Silvestre R, Tavares J, Silva M, Cabral S, Maciel J, Cordeiro-Da-Silva A. Immune response regulation by Leishmania secreted and non secreted antigens. J Biomed Biotechnol 2007 6 : 851 54.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951 193 : 265 75.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987 162 : 156 9.
22. Burdin N, Rousset F, Banchereau J. B-cell-derived IL-10: production and function. Methods 1997 11 : 98 111.
23. Nogoceke E, Gommel DU, Kiess M, Kalisz HM, Flohe L. A unique cascade of oxidoreductases catalyses trypanothione-mediated peroxide metabolism in Crithidia fasciculata. Biol Chem 1997 378 : 827 36.
24. Morrison DC, Ryan JL. Bacterial endotoxins and host immune responses. Adv Immunol 1979 28 : 293 450.
25. Sacks DL, Scott PA, Asofsky R, Sher FA. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J Immunol 1984 132 : 2072 7.
26. Kima PE, Constant SL, Hannum L, Colmenares M, Lee KS, Haberman AM, Shlomchik MJ, McMahon-Pratt D. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J Exp Med 2000 191 : 1063 8.
27. Chuenkova M, Pereira ME. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease. J Exp Med 1995 181 : 1693 703.
28. Belen Carrillo M, Gao W, Herrera M, Alroy J, Moore JB, Beverley SM, Pereira MA. Heterologous expression of Trypanosoma cruzi trans-sialidase in Leishmania major enhances virulence. Infect Immun 2000 68 : 2728 34.
29. Gao W, Wortis HH, Pereira MA. The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion. Int Immunol 2002 14 : 299 308.
30. Kaye PM, Curry AJ, Blackwell JM. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J Immunol 1991 146 : 2763 70.
31. Engwerda CR, Smelt SC, Kaye PM. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice. Exp Parasitol 1996 84 : 195 202.
32. Fowell DJ, Bix M, Shinkai K, Lacy D, Locksley RM. Disease susceptibility and development of the cytokine repertoire in the murine Leishmania major model. Eur Cytokine Netw 1998 9 : 102 6.
33. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 1993 177 : 1797 802.
34. Maekawa Y, Himeno K, Ishikawa H et al. Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. J Immunol 1998 161 : 2120 7.
35. Belkaid Y, Hoffmann KF, Mendez S, Kamhawi S, Udey MC, Wynn TA, Sacks DL. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 2001 194 : 1497 506.
36. Kane MM, Mosser DM. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 2001 166 : 1141 7.
37. Murray HW, Lu CM, Mauze S, Freeman S, Moreira AL, Kaplan G, Coffman RL. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect Immun 2002 70 : 6284 93.
38. Murphy ML, Wille U, Villegas EN, Hunter CA, Farrell JP. IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol 2001 31 : 2848 56.
39. Bermudez LE, Champsi J. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun 1993 61 : 3093 7.
40. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 1995 155 : 722 9.
41. Lesinski GB, Westerink MA. Novel vaccine strategies to T-independent antigens. J Microbiol Meth 2001 47 : 135 49.
42. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol 2006 176 : 705 10.
43. Palanivel V, Posey C, Horauf AM, Solbach W, Piessens WF, Harn DA. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp Parasitol 1996 84 : 168 77.
44. Velupillai P, Harn DA. Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci USA 1994 91 : 18 22.
45. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol 1993 11 : 501 38.
46. O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992 22 : 711 7.
47. O'Garra A, Howard M. Cytokines and Ly-1 (B1) B cells. Int Rev Immunol 1992 8 : 219 34.
48. Fagarasan S, Honjo T. T-independent immune response: new aspects of B cell biology. Science 2000 290 : 89 92.
49. Bunn-Moreno MM, Madeira ED, Miller K, Menezes JA, Campos-Neto A. Hypergammaglobulinaemia in Leishmania donovani infected hamsters: possible association with a polyclonal activator of B cells and with suppression of T cell function. Clin Exp Immunol 1985 59 : 427 34.
50. Lohoff M, Matzner C, Rollinghoff M. Polyclonal B-cell stimulation by L3T4+ T cells in experimental leishmaniasis. Infect Immun 1988 56 : 2120 4.
51. Olivier M, Gregory DJ, Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev 2005 18 : 293 305.
52. Grimaldi G Jr., Tesh RB. Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev 1993 6 : 230 50.
53. Da Silva AC, Espinoza AG, Taibi A, Ouaissi A, Minoprio P. A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator. Immunology 1998 94 : 189 96.
54. Cordeiro-da-Silva A, Cardoso L, Araujo N et al. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications. Immunol Lett 2003 86 : 155 62.
55. Bjorklund M, Coutinho A. Isotype commitment in the in vivo immune responses. II. Polyclonal plaque-forming cell responses to lipopolysaccharide in the spleen and bone marrow. Eur J Immunol 1983 13 : 44 50.
56. Castro H, Sousa C, Santos M, Cordeiro-da-Silva A, Flohe L, Tomas AM. Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum. Free Radic Biol Med 2002 33 : 1552 62.
57. Santarem N, Tomas A, Ouaissi A et al. Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment. Immunol Lett 2005 101 : 18 23.
58. Brittingham A, Chen G, McGwire BS, Chang KP, Mosser DM. Interaction of Leishmania gp63 with cellular receptors for fibronectin. Infect Immun 1999 67 : 4477 84.
59. Rittig MG, Bogdan C. Leishmania-host-cell interaction: complexities and alternative views. Parasitol Today 2000 16 : 292 7.
60. Stober CB, Lange UG, Roberts MT, Alcami A, Blackwell JM. Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB/c mice. Infect Immun 2007 75 : 852 60.